There's enough funds to see their pipeline through to Ph2 but if IMU are going alone to Ph3 then they will need a lot of funds. By then, the pps will be worth a lot more as this is when BP offers premium price when IP have completed Ph2 clinical trial since they will have enough data to demonstrate efficacy.
There's enough funds to see their pipeline through to Ph2 but if...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $512.3M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $922.0K | 13.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 702419 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 1365317 | 9 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
-0.001 ( 1.69 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.1¢ | 6.8¢ | 5455105 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| IMU (ASX) Chart |